Table 6. Associations between the expression levels of CCR7 and FOXP3 and clinical characteristics.
Characteristics | FOXP3 expression | CCR7 expression | ||||
Low | High | P | Low | High | P | |
Gender | ||||||
Male | 36 | 53 | 0.057 | 29 | 60 | 0.078 |
Female | 10 | 34 | 11 | 33 | ||
Age (years) | ||||||
<60 | 22 | 46 | 0.325 | 18 | 50 | 0.402 |
≥60 | 24 | 41 | 22 | 43 | ||
Tumor size (mm) | ||||||
<40 | 26 | 53 | 0.183 | 22 | 57 | 0.115 |
≥40 | 20 | 34 | 18 | 36 | ||
Lymphatic invasion | ||||||
Negative | 27 | 31 | 0.059 | 30 | 28 | 0.012 |
Positive | 19 | 56 | 10 | 65 | ||
Lymph node metastasis | ||||||
Negative | 34 | 15 | 0.024 | 33 | 16 | 0.009 |
Positive | 12 | 72 | 7 | 77 | ||
Histological type | ||||||
Undifferentiated | 25 | 36 | 0.195 | 26 | 35 | 0.167 |
Differentiated | 21 | 51 | 14 | 58 | ||
T Classification | ||||||
T1T2 | 22 | 28 | 0.153 | 17 | 33 | 0.441 |
T3T4 | 24 | 59 | 23 | 60 |